申请人:BioNumerik Pharmaceuticals, Inc.
公开号:US06504049B1
公开(公告)日:2003-01-07
A process for synthesizing pharmaceutically active disulfides, particularly Dimesna and certain derivatives thereof. The process includes reacting an alkylene salt with a sulfurating reagent, then alkalizing the intermediate and flowing oxygen through the mixture to produce the final compound in high yield.
一种合成药物活性二
硫化物的过程,特别是Dimesna和其某些衍
生物。该过程包括将烷基盐与
硫化试剂反应,然后碱化中间体,并通过混合物通入
氧气以高收率产生最终化合物。